Carregant...
Immune checkpoint inhibitors in cancer therapy
In recent years immune checkpoint inhibitors have garnered attention as being one of the most promising types of immunotherapy on the horizon. There has been particular focus on the immune checkpoint molecules, cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein 1 (PD-1) whic...
Guardat en:
| Publicat a: | J Biomed Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Editorial Department of Journal of Biomedical Research
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163118/ https://ncbi.nlm.nih.gov/pubmed/28866656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7555/JBR.31.20160168 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|